- Home
- Equipment
- australasia
- drug administration
Show results for
Refine by
Drug Administration Equipment Supplied In Australasia
7 equipment items found
Manufactured by:Baymatob Operations Pty. Ltd based inLeichhardt, AUSTRALIA
Oli PPH is the only product to have ever demonstrated the ability to identify women who are at higher risk of developing postpartum hemorrhage well before they give birth, allowing for early prediction and clinical actions to prevent the leading cause of preventable maternal death. Oli PPH was recently granted Breakthrough Device Designation by the U.S. Food and Drug ...
Manufactured by:Interscan Corporation based inCamas, WASHINGTON (USA)
Research has indicated that hydrogen sulfide, methyl mercaptan, other thiols, and dimethyl sulfide, collectively referred to as volatile sulfur compounds (VSC), are the principal malodorants in chronic halitosis. These compounds are generated by anaerobic bacteria, located principally on the back of the tongue. The American Dental Association confirms that millions of people suffer from this ...
Manufactured by:PolyActiva Pty Ltd. based inParkville, AUSTRALIA
Being developed to reduce IOP caused by Open-Angle Glaucoma & Ocular Hypertension. Clinical Investigation Stage: Phase ...
Manufactured by:PolyActiva Pty Ltd. based inParkville, AUSTRALIA
Being developed to reduce the risk of Endophthalmitis following ocular (cataract) surgery. Clinical Investigation Stage: Phase ...
Manufactured by:Camurus AB based inLund, SWEDEN
FluidCrysta nanoparticles can resolve bioavailability issues for water and lipid-soluble pharmaceuticals or biodegradation-sensitive drugs, such as peptides and proteins. FluidCrystal nanoparticles are usually water-based and comprise a stable emulsion of nanoparticles with a liquid crystalline structure. Investigational medicinal products based on this technology are administered either ...
by:AdAlta Limited based inBundoora, AUSTRALIA
A specific form of lung fibrosis is Idiopathic pulmonary fibrosis (IPF), which is a chronic and ultimately fatal disease, where tissue deep in the lungs becomes scarred, over time, resulting in a progressive decline in lung function and shortness of breath. There is currently no cure for IPF with most people living only three to five years after diagnosis. The rate at which the disease progresses ...
Manufactured by:ErtelAlsop based inKingston, NEW YORK (USA)
The pharmaceutical and biotech markets require a high level of functional consistency from filtration products. To provide a higher level of confidence for these customers, ErtelAlsop drafted its Drug Master File and submitted it to the FDA Center for Drug Evaluation and Research. ErtelAlsop manufactures all filter pads to very high standards, and the Drug Master File provides the documentation ...